Volteface’s latest report examining clinician perspectives on medical cannabis by Katya Kowalski. Volteface has been researching the barriers and hesitations faced by clinicians in the UK toward feeling comfortable and confident in prescribing medical cannabis. “Known Unknowns” represents a dive deep into the perceptions, concerns, and hopes of UK clinicians for medical cannabis. This report recognizes that in order to move forward, the industry faces challenges, and for cannabis to become mainstream as a treatment, a number of concerns that currently exist amongst clinicians must be addressed.
The report points out Syqe® for developing an innovative delivery platform that provides a consistent, metered dose with high bioavailability in a way that looks and feels like a medical product a clinician would prescribe. Read the full report>>
One Response
Such skill!